Massa Medicata Fermentata (MMF) processed by stir-frying reduces Helicobacter pylori burden in a gastritis mouse model

Ethnopharmacological relevance Helicobacter pylori ( H. pylori ) is the only confirmed pathogenic bacterium that can persistently colonize the stomach and cause gastric mucosal inflammation and related diseases. Massa Medicata Fermentata (MMF), a classical traditional fermented Chinese medicine, is commonly used clinically—either unprocessed or stir-fried—to treat gastric disorders such as dyspepsia; however, its pharmacological mechanisms against H. pylori infection remain unclear. Objective To comparatively analyze the antibacterial effects of naturally fermented MMF and its stir-fried MMF on H. pylori in vivo and in vitro . Materials and method Naturally fermented MMF was stir-fry processed for different durations to produce three types: golden-, aromatic-, and charred-MMF; their biochemical characteristics and components were then evaluated. Co-culture experiments assessed the effects of MMF on H. pylori growth in vitro . Finally, a mouse H. pylori infection model was established; interventions with the four MMF types, alone or combined with anti- H. pylori immunoglobulin Y (IgY- Hp ), were administered for 2 weeks, and both H. pylori burden and gastrointestinal function were measured. Results Naturally fermented MMF exerted a direct effect on the growth and infection of H. pylori . Stir-fry processing not only markedly altered MMF appearance and biochemical profiles, but also enhanced its inhibitory activity against H. pylori growth. In H. pylori –infected mice, aromatic- and charred-MMF reduced gastric H. pylori burden, with 37.5% of treated animals (3/8) testing RUT-negative versus 25% for original MMF. Interestingly, combining MMF with IgY- Hp further enhanced the anti- H. pylori activity of MMF; notably, the aromatic-MMF + IgY- Hp group demonstrated a synergistic inhibitory effect on H. pylori growth (FICI = 0.5) and achieved the largest reduction in H. pylori burden in vivo , with 62.5% of treated animals (5/8) testing RUT-negative. This group also showed significantly improved gastrointestinal function, including gastric emptying and small-intestinal propulsion (p < 0.05), as well as serum gastrin, motilin, and somatostatin levels. Further GC-MS analysis revealed that stir-frying markedly altered the chemical components of MMF, such as 5-hydroxymethylfurfural (5-HMF) and 1-Ethyl-2-formylpyrrole, whose changes are consistent with the variation in antibacterial activity of stir-fried MMF. Conclusion Stir-fry processing significantly altered the appearance, biochemical profile, and composition of MMF and exerted a significantly stronger anti- H. pylori effect, especially for aromatic-MMF, compared with naturally fermented MMF. In addition, MMF combined with IgY- Hp significantly increased antibacterial activity in vitro and in vivo and promoted recovery of gastrointestinal function, suggesting a potentially effective and non-antibiotic therapeutic option.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-18
DOI
https://doi.org/10.3389/fphar.2026.1934298
Primary Topic
Helicobacter pylori-related gastroenterology studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Massa Medicata Fermentata (MMF) processed by stir-frying reduces Helicobacter pylori burden in a gastritis mouse model

Xiao‐Hong Jian, 小玲 骆, Rong Guo, Nanlin Chen et al.
Frontiers in Pharmacology
Helicobacter pylori-related gastroenterology studies
article

Massa Medicata Fermentata (MMF) processed by stir-frying reduces Helicobacter pylori burden in a gastritis mouse model

Xiao‐Hong Jian, 小玲 骆, Rong Guo, Nanlin Chen, Zaixin Li, Zhi Zhang, Ruilin Xie, Bin Wang, Hao Jiang, Meifang Du, Taibing Yang
article en

Abstract

Ethnopharmacological relevance Helicobacter pylori ( H. pylori ) is the only confirmed pathogenic bacterium that can persistently colonize the stomach and cause gastric mucosal inflammation and related diseases. Massa Medicata Fermentata (MMF), a classical traditional fermented Chinese medicine, is commonly used clinically—either unprocessed or stir-fried—to treat gastric disorders such as dyspepsia; however, its pharmacological mechanisms against H. pylori infection remain unclear. Objective To comparatively analyze the antibacterial effects of naturally fermented MMF and its stir-fried MMF on H. pylori in vivo and in vitro . Materials and method Naturally fermented MMF was stir-fry processed for different durations to produce three types: golden-, aromatic-, and charred-MMF; their biochemical characteristics and components were then evaluated. Co-culture experiments assessed the effects of MMF on H. pylori growth in vitro . Finally, a mouse H. pylori infection model was established; interventions with the four MMF types, alone or combined with anti- H. pylori immunoglobulin Y (IgY- Hp ), were administered for 2 weeks, and both H. pylori burden and gastrointestinal function were measured. Results Naturally fermented MMF exerted a direct effect on the growth and infection of H. pylori . Stir-fry processing not only markedly altered MMF appearance and biochemical profiles, but also enhanced its inhibitory activity against H. pylori growth. In H. pylori –infected mice, aromatic- and charred-MMF reduced gastric H. pylori burden, with 37.5% of treated animals (3/8) testing RUT-negative versus 25% for original MMF. Interestingly, combining MMF with IgY- Hp further enhanced the anti- H. pylori activity of MMF; notably, the aromatic-MMF + IgY- Hp group demonstrated a synergistic inhibitory effect on H. pylori growth (FICI = 0.5) and achieved the largest reduction in H. pylori burden in vivo , with 62.5% of treated animals (5/8) testing RUT-negative. This group also showed significantly improved gastrointestinal function, including gastric emptying and small-intestinal propulsion (p < 0.05), as well as serum gastrin, motilin, and somatostatin levels. Further GC-MS analysis revealed that stir-frying markedly altered the chemical components of MMF, such as 5-hydroxymethylfurfural (5-HMF) and 1-Ethyl-2-formylpyrrole, whose changes are consistent with the variation in antibacterial activity of stir-fried MMF. Conclusion Stir-fry processing significantly altered the appearance, biochemical profile, and composition of MMF and exerted a significantly stronger anti- H. pylori effect, especially for aromatic-MMF, compared with naturally fermented MMF. In addition, MMF combined with IgY- Hp significantly increased antibacterial activity in vitro and in vivo and promoted recovery of gastrointestinal function, suggesting a potentially effective and non-antibiotic therapeutic option.

Frontiers in PharmacologyVol. 17
Yibin University (CN), Sichuan University of Science and Engineering (CN)
Good health and well-being
Helicobacter pylori-related gastroenterology studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon